DNA Methylation and Histone Modification Regulate Silencing of Epithelial Cell Adhesion Molecule for Tumor Invasion and Progression
Overview
Affiliations
Epithelial cell adhesion molecule (Ep-CAM) is believed to have a critical role in carcinogenesis and cell proliferation. However, the association of Ep-CAM with cancer invasion and progression is less clear. We found that Ep-CAM was highly expressed on low-invasive cells compared with highly invasive cells. Forced expression of Ep-CAM decreased cancer invasiveness, and silencing Ep-CAM expression elevated cancer invasiveness. Ep-CAM expression was associated with promoter methylation. Treatment with a demethylating agent, and/or the histone deacetylase inhibitor reactivated Ep-CAM expression in Ep-CAM-negative cells and inhibited cancer invasiveness. Using a promoter-reporter construct, we demonstrated methylation of the promoter fragment drive Ep-CAM-silenced transcription. Additionally, silenced Ep-CAM gene in cancer cells was enriched for hypermethylated histone 3 lysine 9. When unmethylated and active, this promoter was associated with acetylated histone 3 lysine 9. Furthermore, we observed an increased association of Ep-CAM promoter with repression components as tumor invasiveness increased. In cancer tissues, Ep-CAM expression significantly correlated with tumor progression and associated with promoter methylation. Our data support the idea that modulation of Ep-CAM plays a pivotal role in tumor invasion and progression. Moreover, aberrant DNA methylation of Ep-CAM is implicated in enhancing invasive/metastatic proclivity of tumors.
Chang C, Tsai C, Tsai F, Chu T, Hsu P, Kuo C Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996844 PMC: 11854592. DOI: 10.3390/cimb47020123.
Regulation of the Function and Expression of EpCAM.
Xiao D, Xiong M, Wang X, Lyu M, Sun H, Cui Y Biomedicines. 2024; 12(5).
PMID: 38791091 PMC: 11117676. DOI: 10.3390/biomedicines12051129.
Bora Yildiz C, Kundu T, Gehrmann J, Koesling J, Ravaei A, Wolff P Epigenetics Chromatin. 2023; 16(1):42.
PMID: 37880732 PMC: 10601256. DOI: 10.1186/s13072-023-00516-4.
Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
Alwadi D, Felty Q, Yoo C, Roy D, Deoraj A Int J Mol Sci. 2023; 24(4).
PMID: 36834602 PMC: 9959535. DOI: 10.3390/ijms24043191.
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside.
Liu Y, Wang Y, Sun S, Chen Z, Xiang S, Ding Z Exp Hematol Oncol. 2022; 11(1):97.
PMID: 36369033 PMC: 9650829. DOI: 10.1186/s40164-022-00352-4.